AM2018 JS03 ASTRO-ASCO Joint Session: Genomics to Personalize Breast Cancer Treatment: On the Evolving Road to Minimize Overtreatment
Panel session will update the practicing clinician with respect to the ever-evolving genomic profiling data in breast cancer and its application to the therapeutic management of the breast cancer patient in terms of the three subspecialties of breast oncology - that of medical, surgical and radiation oncology. The experts will elucidate how molecular subtyping is changing the role of the oncologist in each of the 3 branches of cancer treatment. As well the panel will address the practical issues related to translating research findings into clinical practice in a timely fashion.
The meeting is designed to meet the interests of radiation oncologists, medical oncologists, radiation oncologists, surgeons, nurses, radiation therapists, radiation biologists, pathologists, and residents.
- Describe relevant genomic/molecular subtyping of breast cancer as opposed to the classic categorization via TNM staging.
- Assess the utility of molecular subtyping of breast cancer in the application of the genomic information into the treatment paradigm of caring for a patient with breast cancer.
The following persons served as faculty for this activity: Peter Chen, MD, Laura Esserman, MD, MBA, Eleanor Harris, MD, Shelley Hwang, MD, MPH, Abram Recht, MD, and Douglas Yee, MD.
Additionally, the SA-CME Task Force and the CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.